In a phase 2 trial, once-monthly dosing produced significant weight loss at 52 weeks: 12.3% to 16.2% in patients with obesity without diabetes ( vs 2.5% with placebo), and 8.4% to -12.3% in those with obesity and type 2 diabetes ( vs 1.7% with placebo)
Through these combined actions, GHK-Cu not only supports skin rejuvenation but also contributes to overall skin vitality, making it a valuable component in both cosmetic and therapeutic applications aimed at enhancing skin health and appearance
GHK-Cu may be beneficial for: Individuals with fine lines, wrinkles, uneven skin tone, or decreased skin firmness and density
Tirzepatide formulations that include additional compounds like glycine and B12 , niacinamide , or levocarnitine introduce additional variables that may affect local tolerability
However, they have separate FDA approvals for different conditions
Mix in Cardiovascular Work Walking, cycling, swimming, or other aerobic activities are excellent for heart health, appetite regulation, and fat management